Literature DB >> 26992308

Concurrent venography during first rib resection and scalenectomy for venous thoracic outlet syndrome is safe and efficient.

Alexander T Hawkins1, Maria J Schaumeier1, Ann D Smith1, Marit S de Vos2, Karen J Ho1, Marcus E Semel1, Louis L Nguyen3.   

Abstract

OBJECTIVE: Surgical treatment of acute axillosubclavian vein thrombosis from venous thoracic outlet syndrome (VTOS) traditionally involves first rib resection and scalenectomy (FRRS) followed by interval venography and balloon angioplasty. This approach can lead to an extended need for anticoagulation and a separate anesthesia session. We present outcomes for FRRS with concurrent venography.
METHODS: Retrospective chart review was performed for consecutive patients undergoing FRRS with concurrent venography for VTOS from February 2007 to April 2014. Venography was performed immediately after FRRS with the arm in neutral and provocative positions. The primary outcomes of this study were primary and primary-assisted patency. Secondary outcomes included whether concurrent venography resulted in modification of the procedure, postoperative anticoagulation use, and postoperative complications.
RESULTS: Thirty patients underwent first rib resection with venography with a mean follow-up time of 24.4 months. The mean age was 29.5 years (range, 17-52 years), and 17 (56.7%) were female. All were maintained on anticoagulation before the procedure. Concurrent venography resulted in modification of the procedure in 28 patients (93.3%). Of these, 27 patients (96.4%) underwent balloon angioplasty and two patients (7.1%) underwent further rib resection. Twenty patients (66.7%) were discharged after the procedure with no anticoagulation. For those receiving postoperative anticoagulation for persistent minor thrombus, median time for anticoagulation duration was 5.0 months (range, 0.8 and 16.7 months). Two patients (6.7%) had postoperative bleeding requiring thoracentesis or video-assisted thoracoscopic evacuation of hemothorax. One patient (3.3%) suffered rethrombosis and was successfully lysed open, resulting in a 2-year subclavian vein (SCV) primary patency of 96.7% and primary-assisted patency of 100%. No patients required reoperation for VTOS, and all reported improvements in symptoms. Three patients (10.0%) later underwent prophylactic first rib resection on the contralateral side for symptoms and SCV stenosis.
CONCLUSIONS: FRRS with concurrent venography is a safe procedure for VTOS that allows effective intraoperative modification of the surgical plan, resulting in excellent patency of the SCV, early cessation of anticoagulation, and durable relief of symptoms.
Copyright © 2015. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2014        PMID: 26992308      PMCID: PMC4800744          DOI: 10.1016/j.jvsv.2014.09.010

Source DB:  PubMed          Journal:  J Vasc Surg Venous Lymphat Disord


  22 in total

1.  Safety and efficacy of early surgical decompression of the thoracic outlet for Paget-Schroetter syndrome.

Authors:  N Angle; H A Gelabert; M M Farooq; S S Ahn; D R Caswell; J A Freischlag; H I Machleder
Journal:  Ann Vasc Surg       Date:  2001-01       Impact factor: 1.466

2.  Paget-Schroetter syndrome: what is the best management?

Authors:  H C Urschel; M A Razzuk
Journal:  Ann Thorac Surg       Date:  2000-06       Impact factor: 4.330

3.  Venous obstruction in the upper extremity.

Authors:  E S R HUGHES
Journal:  Br J Surg       Date:  1948-10       Impact factor: 6.939

Review 4.  Venous thoracic outlet compression and the Paget-Schroetter syndrome: a review and recommendations for management.

Authors:  J F Thompson; R J Winterborn; S Bays; H White; D C Kinsella; A F Watkinson
Journal:  Cardiovasc Intervent Radiol       Date:  2011-03-30       Impact factor: 2.740

5.  Preoperative thrombolysis and venoplasty affords no benefit in patency following first rib resection and scalenectomy for subacute and chronic subclavian vein thrombosis.

Authors:  James Lawrence Guzzo; Kevin Chang; Jasmine Demos; James H Black; Julie A Freischlag
Journal:  J Vasc Surg       Date:  2010-09       Impact factor: 4.268

Review 6.  Contemporary management of thoracic outlet syndrome.

Authors:  Benjamin S Brooke; Julie A Freischlag
Journal:  Curr Opin Cardiol       Date:  2010-11       Impact factor: 2.161

7.  Paget-Schroetter syndrome treated with thrombolytics and immediate surgery.

Authors:  J Ernesto Molina; David W Hunter; Charles A Dietz
Journal:  J Vasc Surg       Date:  2007-02       Impact factor: 4.268

Review 8.  Diagnosis of thoracic outlet syndrome.

Authors:  Richard J Sanders; Sharon L Hammond; Neal M Rao
Journal:  J Vasc Surg       Date:  2007-09       Impact factor: 4.268

9.  Comprehensive surgical management of the competitive athlete with effort thrombosis of the subclavian vein (Paget-Schroetter syndrome).

Authors:  Spencer J Melby; Suresh Vedantham; Vamsidhar R Narra; George A Paletta; Lynnette Khoo-Summers; Matt Driskill; Robert W Thompson
Journal:  J Vasc Surg       Date:  2008-02-14       Impact factor: 4.268

10.  Management of effort thrombosis of the subclavian vein: today's treatment.

Authors:  Adam Doyle; Heather Y Wolford; Mark G Davies; James T Adams; Michael J Singh; Wael E Saad; David L Waldman; James A Deweese; Karl A Illig
Journal:  Ann Vasc Surg       Date:  2007-10-17       Impact factor: 1.466

View more
  2 in total

Review 1.  Lower extremity CT angiography in peripheral arterial disease: from the established approach to evolving technical developments.

Authors:  Omar Shwaiki; Basem Rashwan; Matthias A Fink; Levester Kirksey; Sameer Gadani; Karunakaravel Karuppasamy; Claudius Melzig; Dustin Thompson; Giuseppe D'Amico; Fabian Rengier; Sasan Partovi
Journal:  Int J Cardiovasc Imaging       Date:  2021-05-17       Impact factor: 2.357

2.  Venous thoracic outlet syndrome secondary to arterial stent implantation: A case report.

Authors:  Yang Liu; Zhoupeng Wu; Bin Huang; Yi Yang; Jichun Zhao; Yukui Ma
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.